← All stocks

Black Diamond Therapeutics, Inc.

BDTX No buying or selling

CIK 0001701541 #4227 in the set updated 19 Sep 2026

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

$0.00

$0.00 against sales at will

By person

9 insiders · 0 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

BIOTECH GROWTH N V

10% owner

—

2,733,547

4.76%

$5.79M

−67.9%

Buck Elizabeth

CHIEF SCIENTIFIC OFFICER

—

170,192

0.2962%

$360.28K

+78.8%

Velleca Mark A.

PRESIDENT & CEO

—

121,522

0.2115%

$257.25K

+161.2%

Behbahani Ali

Director

—

102,529

0.1785%

$217.04K

+87.9%

Jones Erika

SEE REMARKS

—

85,150

0.1482%

$180.25K

+738.9%

Hatzis-Schoch Brent

SEE REMARKS

—

83,400

0.1452%

$176.55K

+892.9%

Yurasov Sergey

CHIEF MEDICAL OFFICER

—

75,000

0.1305%

$158.77K

—

Raman Prakash

Director

—

45,039

0.0784%

$95.34K

+1,857%

Campbell Shannon

Director

—

8,865

0.0154%

$18.77K

+340.8%

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 19

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 47,899

History held since 31 Jan 2020